Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629163 | 0.95 | LMNA (0.46) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL15381998 | 0.86 | TSHR (0.47) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL14514222 | 0.86 | TSHR (0.47) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL10384825 | 0.82 | LMNA (0.46) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL11768405 | 0.81 | CES1 (0.45) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL14237206 | 0.81 | TSHR (0.46) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL10942987 | 0.81 | PPARA (0.46) | TSHRCES2CES1TP53LMNA | |
| SCHEMBL13754160 | 0.80 | CES1 (0.55) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL9303826 | 0.80 | CES1 (0.55) | TSHRCES2CES1TP53CYP3A4 | |
| SCHEMBL11083344 | 0.80 | TDP1 (0.48) | TSHRCES1MAPK1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9402793-B2 | Use of UV-filters to stabilize resveratrol in topical cosmetic compositions | DSM IP ASSETS B.V. (NL) | 2016-08-02 | — | — | US | claimed |
| US-20130324616-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2013-12-05 | — | — | US | claimed |
| US-20130315848-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2013-11-28 | — | — | US | claimed |
| EP-2642972-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| EP-2642973-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| WO-2012069362-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2012-05-31 | — | — | WO | claimed |
| WO-2012069363-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2012-05-31 | — | — | WO | claimed |
| WO-2004062635-A1 | COMPOSITIONS FOR SKIN LIGHTENING COMPRISING BIS-PANTOYL-CYSTAMINE | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | claimed |
| CN-113616540-B | Novel occlusive formulations | 株式会社LG生活健康 | 2023-11-03 | — | — | CN | disclosed |
| CN-116634983-A | Elastomeric gel from epoxidized vegetable oil and uses thereof | 迈图高新材料公司 | 2023-08-22 | — | — | CN | disclosed |
| EP-3033066-B1 | POLYUREA OR POLYURETHANE CAPSULES | INT FLAVORS & FRAGRANCES INC (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-4209264-A1 | MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS | International Flavors & Fragrances Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20230172820-A1 | Compositions Containing Microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-06-08 | — | — | US | disclosed |
| EP-3512625-B1 | MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS | INT FLAVORS & FRAGRANCES INC (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-101415402-A | UV-stable liquid or semisolid transdermal delivery form comprising a light-sensitive active ingredient | SCHERING AKTI ENGESELLSCHAFT (DE) | 2009-04-22 | — | — | CN | disclosed |
| US-7381769-B2 | Cosmetic compositions using polyether siloxane copolymer network compositions | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-06-03 | — | — | US | disclosed |
| CN-1826126-A | Plant extract with prebiotic activity | HENKEL KGAA (DE) | 2006-08-30 | — | — | CN | disclosed |
| CN-1678339-A | Synergistic combination of silk proteins | HENKEL KGAA (DE) | 2005-10-05 | — | — | CN | disclosed |
| US-20050197477-A1 | Cosmetic compositions using polyether siloxane copolymer network compositions | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-09-08 | — | — | US | disclosed |
| WO-1992017159-A2 | STABILIZED EMULSION COMPOSITIONS FOR IMPARTING AN ARTIFICIAL TAN TO HUMAN SKIN | RICHARDSON-VICKS INC. (US) | 1992-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172820-A1 | Compositions Containing Microcapsules | COPE, SAAL1, AUP1 | TSHR 3290/4885CES2 2972/4885CES1 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.